Reviva Pharmaceuticals Holdings Inc. (RVPH) is a Healthcare · Biotechnology company listed on NASDAQ. Price $0.50 (+2.47%), Market cap $0.01B, 52-week low–high $0.18 ~ $2.88.
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, such as schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis. It also engages in the clinical development for respiratory indications, such as pulmo
Financial statements, price targets, institutional (13F) holdings and related news for Reviva Pharmaceuticals Holdings Inc. are updated in real time on BlackAll Trade.
Reviva Pharmaceuticals Holdings Inc. trades at $0.50 (+2.47%). Real-time quotes and charts are available on BlackAll Trade.
Reviva Pharmaceuticals Holdings Inc. has a market cap of about $0.01B.
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of cent